Transform Real-World
Healthcare Data Into
Decision-Grade Evidence

Improved Formulary Position

Symetrique helps life sciences teams build compelling, real-world evidence to support stronger formulary placement and coverage decisions. By integrating claims, EHR, and longitudinal patient data, our platform enables comparative effectiveness analyses across real-world populations and care settings. We quantify how therapies perform outside controlled trials—across adherence, persistence, healthcare utilization, and clinical outcomes—providing payers with the evidence they need to evaluate true therapeutic value. These insights help strengthen payer dossiers, support tier-placement discussions, and reduce uncertainty during P&T reviews. With transparent methodology and audit-ready analytics, Symetrique enables confident, data-driven engagement with payers and PBMs to improve access and market uptake.

Economic Value Evidence

Demonstrating economic value is critical to achieving sustainable reimbursement. Symetrique enables organizations to quantify the real-world financial impact of therapies using comprehensive cost, utilization, and outcomes data. Our platform supports budget impact models, cost-effectiveness analyses, and healthcare resource utilization studies that reflect actual clinical practice. By combining longitudinal patient journeys with advanced analytics, we help stakeholders understand how therapies influence total cost of care, hospitalization rates, and downstream medical expenses. These insights strengthen pricing strategies, support value-based contracting discussions, and provide credible evidence for HTA submissions—bridging the gap between clinical benefit and economic justification.

Label Expansion Support

Symetrique accelerates evidence generation for new indications, patient segments, and lines of therapy by leveraging real-world data at scale. Our platform enables analysis of safety, effectiveness, and treatment patterns across diverse populations often under-represented in clinical trials. By identifying unmet needs, response variability, and real-world outcomes, we help teams prioritize expansion opportunities and support regulatory and medical affairs strategies. These insights complement clinical development programs and strengthen scientific narratives for supplemental filings and advisory discussions. With robust cohort definition, traceable methodology, and regulatory-aligned analytics, Symetrique enables confident exploration of label expansion pathways.

Optimized Trial Design

Designing efficient and representative trials requires deep understanding of real-world patient populations. Symetrique provides data-driven insights to optimize trial protocols before recruitment begins. Our platform helps teams evaluate eligibility criteria, estimate patient availability, select relevant endpoints, and model expected outcomes using historical real-world cohorts. This reduces protocol amendments, improves enrollment feasibility, and increases external validity of trial results. By grounding trial design in real-world evidence, organizations can shorten timelines, lower operational risk, and ensure studies reflect true clinical practice—improving both scientific rigor and commercial relevance.

Real-Time Querying

Symetrique enables instant exploration of complex healthcare data using natural-language and structured queries. Business users, clinicians, and data scientists can interactively analyze cohorts, outcomes, and utilization patterns without waiting for manual report cycles. Users can ask questions, refine populations, and visualize results in minutes—supporting rapid hypothesis testing, internal decision-making, and cross-functional collaboration. Built-in governance ensures data quality, reproducibility, and compliance while maintaining analytical flexibility. This real-time capability transforms evidence generation from a slow, project-based process into a continuous, on-demand insight engine.

AI/ML Effectiveness

Symetrique embeds advanced AI and machine learning to uncover insights beyond traditional statistical approaches. Our models detect complex treatment-response patterns, predict outcomes, and adjust for real-world confounders to produce reliable comparative effectiveness results. AI-driven analytics enable patient stratification, therapy optimization, and early identification of high-value subpopulations. These capabilities improve the precision of evidence generation while reducing analytical cycle time and human bias. By combining explainable AI with healthcare-grade data pipelines, Symetrique delivers scalable, trustworthy intelligence that drives clinical, regulatory, and commercial decision-making.

Coverage & Reimbursement Evidence

Build compelling evidence packages that demonstrate clinical and economic value to support payer negotiations and formulary placement decisions.

• Cost-effectiveness analyses
• Budget impact modeling
• Comparative outcomes studies

HTA-Ready Packages

Structured evidence submissions aligned with NICE, ICER, and global HTA requirements.

Real-World Value Story

Craft data-driven narratives that communicate therapeutic value to all stakeholders.

Value-Based Contracts

Design and support outcomes-based agreements aligned with real-world evidence. Enable continuous performance monitoring to measure impact, value, and outcomes over time.

Payer Engagement

Evidence-driven engagement strategies for health plans and pharmacy benefit managers.

Optimized Access & Outcomes Tracking

Continuously generate post-launch real-world evidence to demonstrate sustained value, support reimbursement renewals, optimize access strategies, and strengthen long-term payer relationships. Real-world outcomes monitoring Post-launch effectiveness & safety analyses Reimbursement performance tracking Evidence refresh for price reviews & HTA reassessments Access strategy optimization based on live market data